SDX-30330-11234
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 622 / IL
- Registered
- 2021-08-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-06
Dose 1 — Moderna
-
2021-08-12
Registered in v-safe
- 2021-08-12
- 2021-08-13
- 2021-08-20
- 2021-08-27
-
2021-09-03
Dose 2 — Moderna
- 2021-09-03
-
2021-09-10
Survey response — day 7, dose 2MedDRA: Chills, Fatigue, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Pain — Feeling: GoodFree text: The day after 2nd dose I had fatigue, chills, and body aches. At injection site there was redness, swelling, tenderness, and itchiness.MedDRA releases: 2024-11 · check-in free text available
- 2021-09-24
- 2021-10-01
- 2021-10-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-06 | Moderna | No |
| 2 | 2021-09-03 | Moderna | No |
Free text
Release 9 — day 7, dose 2
Systemic reaction (other): The day after 2nd dose I had fatigue, chills, and body aches. At injection site there was redness, swelling, tenderness, and itchiness.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Chills | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Injection site pruritus | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | Pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release